Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
PUT
American Express
AXP
$204B
| $31.2M | 0.01% |
97,700
+81,300
| +496% | +$22.9M |
2024 Q3
3 quarters
|
|
902
Stanley Black & Decker
SWK
$13.8B
| $31.1M | 0.01% |
459,404
+36,649
| +9% | +$2.37M |
2013 Q2
48 quarters
|
|
903
Alignment Healthcare
ALHC
$1.65B
| $31M | 0.01% |
2,217,164
+1,348,143
| +155% | +$21.7M |
2022 Q1
13 quarters
|
|
904
FIVE9
FIVN
$2.57B
| $31M | 0.01% |
1,170,349
+287,704
| +33% | +$7.49M |
2019 Q1
25 quarters
|
|
905
Bunge Global
BG
$20.5B
| $31M | 0.01% |
385,812
-49,625
| -11% | -$3.91M |
2013 Q4
46 quarters
|
|
906
PUT
First Solar
FSLR
$18.8B
| $31M | 0.01% |
187,100
+120,100
| +179% | +$17.7M |
2023 Q4
6 quarters
|
|
907
Indivior Pharmaceuticals
INDV
$4.21B
| $30.9M | 0.01% |
2,099,060
+756,579
| +56% | +$8.81M |
2023 Q2
8 quarters
|
|
908
PUT
HSBC
HSBC
$329B
| $30.9M | 0.01% |
+508,800
| New | +$29M |
2025 Q2
0 quarters
|
|
909
Solventum
SOLV
$15B
| $30.9M | 0.01% |
407,401
+84,354
| +26% | +$5.97M |
2024 Q2
4 quarters
|
|
910
Hormel Foods
HRL
$11.1B
| $30.9M | 0.01% |
1,020,063
+210,865
| +26% | +$6.36M |
2013 Q2
48 quarters
|
|
911
PUT
Charter Communications
CHTR
$12.5B
| $30.8M | 0.01% |
75,300
+74,700
| +12,450% | +$28.6M |
2024 Q3
3 quarters
|
|
912
PUT
Lam Research
LRCX
$435B
| $30.7M | 0.01% |
315,900
+204,600
| +184% | +$16.2M |
2024 Q3
3 quarters
|
|
913
CALL
Apollo Global Management
APO
$67.3B
| $30.7M | 0.01% |
216,200
+47,200
| +28% | +$6.26M |
2024 Q2
4 quarters
|
|
914
Alnylam Pharmaceuticals
ALNY
$29.4B
| $30.7M | 0.01% |
94,058
-1,661
| -2% | -$460K |
2013 Q2
48 quarters
|
|
915
Delek US
DK
$4.54B
| $30.7M | 0.01% |
1,447,682
-192,894
| -12% | -$3.24M |
2013 Q2
48 quarters
|
|
916
Hims & Hers Health
HIMS
$6.77B
| $30.6M | 0.01% |
614,679
+261,314
| +74% | +$11.8M |
2022 Q1
13 quarters
|
|
917
Murphy Oil
MUR
$5.4B
| $30.6M | 0.01% |
1,360,529
+89,208
| +7% | +$1.99M |
2013 Q2
48 quarters
|
|
918
Franklin Templeton
BEN
$16.7B
| $30.6M | 0.01% |
1,283,510
-271,278
| -17% | -$5.59M |
2013 Q2
48 quarters
|
|
919
Cloudflare
NET
$124B
| $30.6M | 0.01% |
156,210
-64,405
| -29% | -$9.35M |
2022 Q1
13 quarters
|
|
920
Norwegian Cruise Line
NCLH
$6.95B
| $30.5M | 0.01% |
1,505,145
+102,206
| +7% | +$1.83M |
2013 Q4
46 quarters
|
|
921
Camden Property Trust
CPT
$11.1B
| $30.3M | 0.01% |
268,769
+1,287
| +0.5% | +$148K |
2013 Q2
48 quarters
|
|
922
CALL
Live Nation Entertainment
LYV
$39.3B
| $30.3M | 0.01% |
200,000
-220,000
| -52% | -$30.3M |
2025 Q1
1 quarter
|
|
923
Telos
TLS
$313M
| $30.2M | 0.01% |
9,529,843
+34,285
| +0.4% | +$89K |
2022 Q1
13 quarters
|
|
924
Rivian
RIVN
$20.7B
| $30.1M | 0.01% |
2,191,444
+434,236
| +25% | +$5.89M |
2022 Q1
13 quarters
|
|
925
CALL
Constellation Brands
STZ
$19.3B
| $30.1M | 0.01% |
185,000
-201,200
| -52% | -$36.1M |
2024 Q4
2 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.